Related Experiment Video
Updated: Jan 6, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Climate Vulnerability Index and Incident Type 2 Diabetes in a Large Integrated Health Care System
Jad Ardakani1, Izza Shahid1, Rakesh Gullapelli1
1Center for Cardiovascular Computational and Precision Health (C3PH), Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas.
Importance:
Place-based Climate Vulnerability Index (CVI) may shape metabolic risk through environmental and socioeconomic stressors, but its association with incident type 2 diabetes (T2D) is not well characterized.
Objective:
To determine whether residence in communities with higher CVI is associated with risk of incident T2D.
Design, Setting, And Participants:
This retrospective cohort study used data from the Houston Methodist Learning Health System Registry, a large integrated health system that primarily serves Greater Houston, Texas. Participants included adults aged 18 years or older without T2D at baseline and with at least 1 outpatient encounter and at least 1 subsequent health care encounter from June 2016 to August 2023. Data analysis was conducted September 2025.
Exposures:
US census tract-level CVI categorized into quartiles (Q1-Q4).
Main Outcomes And Measures:
The primary outcome was incident T2D identified by International Statistical Classification of Diseases, Tenth Revision, Clinical Modification codes, antihyperglycemic prescriptions, or hemoglobin A1c 6.5% or higher. Primary measures were incidence rates (cases per 100 person-years) and adjusted hazard ratios (HRs) with 95% CIs comparing Q4 vs Q1 from Cox models adjusted for demographics, insurance, cardiometabolic risk factors, and baseline hemoglobin A1c.
Results:
Among 1 003 526 participants (mean [SD] age, 50.9 [18.4] years; 605 829 women [60.4%]; 132 451 African American or Black [13.2%]; 71 408 Asian [7.1%]; 156 989 Hispanic or Latinx [15.6%]; 566 632 White [56.5%]; 35 565 other [3.5%]; 42 942 unknown or not reported [4.3%]), 40 152 developed T2D over 2.1 million person-years (overall incidence, 1.88 cases per 100 person-years). Diabetes incidence was higher among participants residing in Q4 vs Q1 CVI areas (2.66 vs 1.48 cases per 100 person-years), and the 7-year risk was 14.1% for Q4 participants vs 8.6% for Q1 participants. Residence in Q4 vs Q1 CVI was associated with higher T2D risk (HR, 1.23; 95% CI, 1.11-1.36), a statistically significant difference.
Conclusions And Relevance:
In this cohort study of 1 003 526 adults, higher community CVI was associated with greater risk of incident T2D independently of traditional risk factors. Linking geocoded CVI to electronic health records may support targeted prevention, risk stratification, and population health planning.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...